Second‐generation antipsychotic‐induced dystonia: Analysis using the Japanese Adverse Drug Event Report ( JADER ) database
Psychiatry and Clinical Neurosciences · 2025
DOI: 10.1111/pcn.13785 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychiatry and Clinical Neurosciences, 2025. Verfasst von Takumi Ebina und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan. Hauptthemen laut MEDLINE: Antipsychotic Agents, Dystonia, Adverse Drug Reaction Reporting Systems. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Aim
This study aimed to explore the comparative risks for dystonia among different second‐generation antipsychotics (SGAs), the influence of sex, and the relationship between the time‐to‐onset of dystonia and its outcomes.
Methods
We analyzed data from the Japanese Adverse Drug Event Report database from April 2004 to November 2023. Cases involving oral SGAs, excluding clozapine, were extracted. We used the odds ratios to assess the reporting proportions among SGAs and sex, analyzed the median time‐to‐onset and interquartile ranges (IQRs), and conducted a receiver operating characteristic (ROC) curve analysis to investigate the time‐to‐onset of dystonia and its relationship to outcomes.
Results
We extracted 9837 cases involving oral SGAs. Lurasidone was associated with a significantly higher proportion of dystonia reports than risperidone, aripiprazole, quetiapine, and olanzapine. The reporting proportion of dystonia associated with aripiprazole was lower than that of paliperidone and risperidone, but higher than that of quetiapine and olanzapine. Female sex was significantly associated with a higher reporting proportion of dystonia compared with males. Among the 148 cases of oral SGA‐induced dystonia, the median time‐to‐onset was 125 days (IQR, 19.75–453.25 days). Divided into the three outcome groups (recovered, improved, and unrecovered/residual), those with better outcomes had a shorter time‐to‐onset than those with poorer outcomes. ROC curve analysis suggested a threshold of 91.5 days for discriminating outcomes, with a sensitivity of 71.7% and specificity of 69.9%.
Conclusions
The risks of dystonia may vary among SGAs and between sexes. SGA‐induced dystonia often manifests in the tardive form.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan.
- Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan.
ORCID-Profile: Takumi Ebina, Kunihiro Iwamoto
Förderung
- Japan Society for the Promotion of Science
- Japan Agency for Medical Research and Development
Zitieren
APA
Ebina, T., Iwamoto, K., Ando, M., & Ikeda, M. (2025). Second‐generation antipsychotic‐induced dystonia: Analysis using the Japanese Adverse Drug Event Report ( JADER ) database. Psychiatry and Clinical Neurosciences. https://doi.org/10.1111/pcn.13785
Vancouver
Ebina T, Iwamoto K, Ando M, Ikeda M. Second‐generation antipsychotic‐induced dystonia: Analysis using the Japanese Adverse Drug Event Report ( JADER ) database. Psychiatry and Clinical Neurosciences. 2025. doi:10.1111/pcn.13785
BibTeX
@article{Ebina2025,
author = {Ebina, Takumi and Iwamoto, Kunihiro and Ando, Masahiko and Ikeda, Masashi},
title = {Second‐generation antipsychotic‐induced dystonia: Analysis using the Japanese Adverse Drug Event Report ( JADER ) database},
journal = {Psychiatry and Clinical Neurosciences},
year = {2025},
doi = {10.1111/pcn.13785}
}
EUVIMED